N4 Pharma Plc (AIM:N4P)
London · Delayed Price · Currency is GBP · Price in GBX 0.5000
+0.0500 (11.11%)
Aug 22, 2025, 4:40 PM GMT+1
N4 Pharma Market Cap
N4 Pharma has a market cap or net worth of 4.16 million as of August 22, 2025. Its market cap has increased by 75.68% in one year.
Market Cap
4.16M
Enterprise Value
3.54M
Revenue
7.28K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.50
Market Cap Chart
Since May 3, 2017, N4 Pharma's market cap has decreased from 4.57M to 4.16M, a decrease of -8.98%. That is a compound annual growth rate of -1.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 4.16M | 100.78% |
| Dec 31, 2024 | 2.07M | -9.28% |
| Dec 29, 2023 | 2.28M | -47.18% |
| Dec 30, 2022 | 4.32M | -46.33% |
| Dec 31, 2021 | 8.06M | -46.71% |
| Dec 31, 2020 | 15.12M | 441.90% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| May 3, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 185.71B |
| GSK plc | 60.14B |
| Haleon | 33.11B |
| Smith & Nephew | 12.13B |
| ConvaTec Group | 4.99B |
| Hikma Pharmaceuticals | 4.03B |
| HUTCHMED (China) | 2.04B |
| Oxford Nanopore Technologies | 2.03B |